Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Consumer Staples Select Sector SPDR Fund (XLP) Price & Performance

ADMA Biologics IncTrade
Consumer Staples Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Consumer Staples Select Sector SPDR Fund — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while Consumer Staples Select Sector SPDR Fund trades at $84.2. The key difference: Consumer Staples Select Sector SPDR Fund is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMAXLP
Market Cap
$2.22B
Sector
Health
52-Week High
$20.38$90.00
52-Week Low
$7.60$75.61
Enterprise Value
$2.29B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Consumer Staples Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as Consumer Staples companies by the GICS®. It is non-diversified.

Read more on XLP